UiPath announces agentic AI solutions for healthcare revenue cycle management at ViVE 2026, targeting medical records review, claim denials and prior authorization. The company argues that ...
Revenue problems and a CEO resignation led to a drop in share price, but UiPath is still growing at decent rates and cash-flow positive. Technology advancements like process mining and task log ...
UiPath is making significant strides in Agentic Automation, partnering with Deloitte and HCLTech to advance AI-driven solutions. UiPath's Q2 results show robust revenue and profitability, but ARR ...
Investors have become less optimistic about the automation company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results